Uploaded image for project: 'eCQM Issue Tracker'
  1. eCQM Issue Tracker
  2. CQM-5908

2023 CMS 69-Adult BMI

XMLWordPrintable

    • Icon: EC eCQMs - Eligible Clinicians EC eCQMs - Eligible Clinicians
    • Resolution: Answered
    • Icon: Moderate Moderate
    • None
    • None
    • Hide
      ​​Thank you for your suggestion regarding CMS69: Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan. We convene a measure expert work group (EWG) annually to review evidence for potential changes to the measure. For the current performance year (PY2024), we have already met and identified potential measure updates. We will discuss the addition of Ozempic, Victoza, Trulicity, and Mounjaro in the "Medications for Above Normal BMI" (2.16.840.1.113883.3.526.3.1561) value set with the EWG during the next Annual Update.
      Show
      ​​Thank you for your suggestion regarding CMS69: Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan. We convene a measure expert work group (EWG) annually to review evidence for potential changes to the measure. For the current performance year (PY2024), we have already met and identified potential measure updates. We will discuss the addition of Ozempic, Victoza, Trulicity, and Mounjaro in the "Medications for Above Normal BMI" (2.16.840.1.113883.3.526.3.1561) value set with the EWG during the next Annual Update.
    • CMS0069v11
    • 2023 CMS 69 - Medications for weight management

      I first requested these meds get added to the list in 2021: Plenity, Saxenda, Contrave, and Weigovy (meds for weight loss)
      New 2023 request: Ozempic, Victoza, Trulicity, and Mounjaro (diabetes meds for weight loss)

            edave Mathematica EC eCQM Team
            temmo1 Moyna P Temple (Inactive)
            Votes:
            0 Vote for this issue
            Watchers:
            2 Start watching this issue

              Created:
              Updated:
              Resolved:
              Solution Posted On: